Related Experiment Video
Updated: Aug 11, 2026
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Immunosuppressive effects of human placental trophoblast interferon-beta on lymphocytes in vitro
M Zdravkovic1, G Aboagye-Mathiesen, V Zachar
1Danish Cancer Society, Department of Virus and Cancer, Aarhus.
Insights
Human placental cells produce interferon-beta (IFN-beta), which suppresses lymphocyte proliferation. This trophoblast-derived IFN-beta may help regulate the maternal immune system during pregnancy.
Area of Science:
- Immunology
- Reproductive Biology
- Virology
Background:
- Human placental trophoblast cells are a source of interferon-beta (IFN-beta) when exposed to viral stimuli.
- IFN-beta plays a crucial role in antiviral defense and immune modulation.
Purpose of the Study:
- To investigate the in vitro antiproliferative effects of trophoblast-derived IFN-beta (tro-IFN-beta) on lymphocytes.
- To compare the antiproliferative activity of tro-IFN-beta with human recombinant IFN-beta.
Main Methods:
- Comparing the effects of tro-IFN-beta and recombinant IFN-beta on mitogen-stimulated and resting lymphocytes.
- Assessing lymphocyte proliferation suppression at various IFN concentrations (10-1000 IU/ml).
Main Results:
- Both tro-IFN-beta and recombinant IFN-beta suppressed lymphocyte proliferation compared to controls.
- The inhibitory effect was significantly greater on stimulated lymphocytes than on resting lymphocytes.
- No significant difference was observed in the antiproliferative efficacy between tro-IFN-beta and recombinant IFN-beta.
Conclusions:
- Human tro-IFN-beta exhibits antiproliferative effects on lymphocytes, similar to recombinant IFN-beta.
- Local production of tro-IFN-beta by the placenta may contribute to controlling maternal immune responses at the fetomaternal interface during pregnancy, beyond its antiviral functions.
Abstract:
Human placental trophoblast cells produce predominantly interferon-beta-type (IFN-beta) when stimulated with viral inducers. The aim of the present study was to determine the in vitro antiproliferative effect of the trophoblast interferon-beta (tro-IFN-beta) on mitogen-stimulated and resting lymphocytes. The antiproliferative effect of the tro-IFN-beta was compared to human recombinant IFN-beta. All activities of tro-IFN-beta and human recombinant IFN-beta ranging between 10-1000 IU/ml showed suppression of proliferative responses on mitogen-stimulated and resting lymphocytes compared to cultures without IFN treatment. The inhibitory level of both tro-IFN-beta and recombinant IFN-beta was significantly higher on the stimulated than on the resting lymphocytes. Although there was a variation in the inhibition of lymphocyte proliferation by both IFNs with respect to time, there was no statistically significant difference in the antiproliferative effect of the IFNs on both resting and mitogen-stimulated lymphocytes. Since IFNs are produced locally by the placenta during pregnancy, our data suggest that in addition to the antiviral activity, the human tro-IFN-beta may participate in the local control of the maternal immune response during pregnancy at the fetomaternal interface.
More Related Videos
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
10:13Purification of HLA-G+ Extravillous Trophoblasts from Human Term Placental Tissues for Phenotyping and Functional Analysis
Published on: March 13, 2026